By Herb Newborg
Swine Flu Scare: It’s All about The Adjuvant!
Pandemic fears used as excuse to bypass safety and efficacy testing of patented adjuvants
The U. S. government has paid pharmaceutical companies $7.9 billion* since 2004 to develop the capacity to mass vaccine the entire U.S. population by 2011. Under the perceived threat of H1N1, these plans have been accelerated to include the use of a non FDA approved chemical adjuvant suspected of causing Gulf War Syndrome, circumventing the FDA approval process for this potentially life threatening chemical.